Brevan Howard Capital Management LP G1 Therapeutics, Inc. Transaction History
Brevan Howard Capital Management LP
- $12.7 Billion
- Q1 2024
A detailed history of Brevan Howard Capital Management LP transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 47,545 shares of GTHX stock, worth $122,190. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,545Holding current value
$122,190% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GTHX
# of Institutions
95Shares Held
14.7MCall Options Held
631KPut Options Held
347K-
Vanguard Group Inc Valley Forge, PA2.08MShares$5.35 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA951KShares$2.44 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny904KShares$2.32 Million0.01% of portfolio
-
Raymond James & Associates St Petersburg, FL803KShares$2.06 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY785KShares$2.02 Million0.0% of portfolio
About G1 Therapeutics, Inc.
- Ticker GTHX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,746,800
- Market Cap $110M
- Description
- G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...